Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1294
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03279055 | Web-based Insomnia Treatment for Adolescent and Young Adult Cancer Survivors | ||
| NCT01629615 | A Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast Cancer | ||
| NCT00004180 | Rosiglitazone in Treating Patients With Liposarcoma | ||
| NCT04936243 | TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance) | ||
| NCT00577642 | Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates | ||
| NCT02172651 | Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases | ||
| NCT00275262 | A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation | ||
| NCT01472627 | Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro | ||
| NCT02926729 | Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy | ||
| NCT01965353 | A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple Myeloma | ||
| NCT01249105 | MK-2206 for Recurrent Malignant Glioma | ||
| NCT03818087 | Elevate! : An Elderly Breast Cancer Cohort Study | ||
| NCT03361852 | Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma | ||
| NCT01283048 | Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma | ||
| NCT01574274 | SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma | ||
| NCT00136487 | Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer | ||
| NCT02041325 | Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias | ||
| NCT03514680 | Clinician Decision Support Algorithm for Chemotherapy-Induced Peripheral Neuropathy | ||
| NCT00859040 | Monthly SOM230C for Recurrent or Progressive Meningioma | ||
| NCT00476476 | Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar | ||
| NCT00165308 | Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors | ||
| NCT00215462 | Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma | ||
| NCT01494662 | HKI-272 for HER2-Positive Breast Cancer and Brain Metastases | ||
| NCT02117336 | Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) | ||
| NCT03740334 | Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL | ||
| NCT00215501 | Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies | ||
| NCT01065467 | Panobinostat (LBH589) in Patients With Metastatic Melanoma | ||
| NCT01670500 | Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa | ||
| NCT01786811 | Serious Illness Communication Project | ||
| NCT03131206 | A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer | ||
| NCT00441142 | Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors | ||
| NCT04930783 | NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma | ||
| NCT04525183 | REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigue | ||
| NCT01253369 | Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer | ||
| NCT06015659 | ZN-c3 + Gemcitabine in Pancreatic Cancer | ||
| NCT00903968 | Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma | ||
| NCT00137774 | Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors | ||
| NCT05795101 | TRUDI: TDXD+Durva in HER2+/Low IBC | ||
| NCT04201145 | Pembrolizumab + Defactinib In Pleural Mesothelioma | ||
| NCT04972253 | Phase I BLASST-3 Trial | ||
| NCT04855695 | Avo In R/R And Previously Untreated MCL | ||
| NCT04732065 | ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors | ||
| NCT03936465 | Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer | ||
| NCT00483223 | Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response | ||
| NCT00927966 | RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms | ||
| NCT00458237 | Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer | ||
| NCT05643027 | A Novel Intervention for Patients With Cancer | ||
| NCT00020670 | Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia | ||
| NCT03762590 | GENetic Education Risk Assessment and TEsting Study | ||
| NCT02698891 | Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer |
